SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001171843-14-003965
Filing Date
2014-08-14
Accepted
2014-08-14 09:00:26
Documents
14
Period of Report
2014-08-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_081414.htm 8-K 26200
2 EXHIBIT 99.1 exh_991.htm EX-99.1 42796
3 EXHIBIT 99.2 exh_992.htm EX-99.2 10249
4 exh992_01.jpg GRAPHIC 118133
5 exh992_02.jpg GRAPHIC 217497
6 exh992_03.jpg GRAPHIC 193652
7 exh992_04.jpg GRAPHIC 133428
8 exh992_05.jpg GRAPHIC 181192
9 exh992_06.jpg GRAPHIC 231398
10 exh992_07.jpg GRAPHIC 201828
11 exh992_08.jpg GRAPHIC 199345
12 exh992_09.jpg GRAPHIC 186431
13 exh992_10.jpg GRAPHIC 171869
14 exh992_11.jpg GRAPHIC 129824
  Complete submission text file 0001171843-14-003965.txt   2788637
Mailing Address 1275 WEST WASHINGTON STREET SUITE 101 TEMPE AZ 85281
Business Address 1275 WEST WASHINGTON STREET SUITE 101 TEMPE AZ 85281 6022865520
Capstone Therapeutics Corp. (Filer) CIK: 0000887151 (see all company filings)

IRS No.: 860585310 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21214 | Film No.: 141039674
SIC: 2834 Pharmaceutical Preparations